0000899243-20-014902.txt : 20200602 0000899243-20-014902.hdr.sgml : 20200602 20200602161736 ACCESSION NUMBER: 0000899243-20-014902 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200529 FILED AS OF DATE: 20200602 DATE AS OF CHANGE: 20200602 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Allen Andrew R CENTRAL INDEX KEY: 0001374539 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35945 FILM NUMBER: 20937165 MAIL ADDRESS: STREET 1: 2525 28TH STREET STREET 2: SUITE 200 CITY: BOULDER STATE: CO ZIP: 80301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Epizyme, Inc. CENTRAL INDEX KEY: 0001571498 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261349956 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 TECHNOLOGY SQUARE STREET 2: 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-229-5872 MAIL ADDRESS: STREET 1: 400 TECHNOLOGY SQUARE STREET 2: 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-05-29 0 0001571498 Epizyme, Inc. EPZM 0001374539 Allen Andrew R C/O CLOVIS ONCOLOGY, INC., 2525 28TH STREET, SUITE 100 BOULDER CO 80301 1 0 0 0 Stock Option (Right to Buy) 17.55 2020-05-29 4 A 0 14013 0.00 A 2030-05-28 Common Stock 14013 14013 D This option will vest in full on May 29, 2021, subject to Reporting Person's continued service as a director. In the event of a change in control of the Issuer, the option will become exercisable in full. /s/ John Weidenbruch, attorney-in-fact 2020-06-02